Lipocine Inc (LPCN) support and resistance · rev $309.5K
Lipocine Inc (LPCN) is a biotechnology company listed on NASDAQ.
This page maps Lipocine Inc (LPCN) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported LPCN revenue for 2026-06-30 was $309.5K. Net income was -$6.3M. LPCN currently screens at market cap $19.3M.
LPCN currently screens at market cap $19.3M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new LPCN 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the LPCN quote page for the session range and the stock page for the full model.
Not investment advice.